Topics › Health Sciences › Medicine › Pulmonary and Respiratory Medicine
Occupational and environmental lung diseases Sign in to save
Papers per year
Papers 42
Open in paper search →-
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial2021 The Lancet article Medicine Occupational and environmental lung diseases Open access cited by 4 patents
Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto, Solange Peters, Anne S. Tsao, Aaron Scott Mansfield, +13 more
1,233citations -
Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations2022 Journal of Thoracic Oncology article Medicine Occupational and environmental lung diseases Open access
Michele Carbone, Harvey Ira Pass, Güntülü Ak, Henry Richard Alexander, Francine Baumann, Andrew M. Blakely, +44 more
96citations -
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743
Arnaud Scherpereel, Scott Joseph Antonia, Francesco Grossi, Dariusz Mirosław Kowalski, Gérard Zalcman, Anna K. Nowak, +10 more
31citations -
Grouping MWCNTs based on their similar potential to cause pulmonary hazard after inhalation: a case-study2022 Particle and Fibre Toxicology article Medicine Occupational and environmental lung diseases Open access
Fiona A Murphy, Nicklas Raun Jacobsen, Emilio Di Ianni, Helinor Jane Johnston, Hedwig Braakhuis, Willie J.G.M. Peijnenburg, +3 more
30citations -
LBA65 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (MPM): 3-year update from CheckMate 743
Solange Peters, Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma, +12 more
16citations -
LBA1 First-line nivolumab (NIVO) plus ipilimumab (IPI) versus chemotherapy (chemo) for the treatment of unresectable malignant pleural mesothelioma (MPM): Patient-reported outcomes (PROs) from CheckMate 743
Arnaud Scherpereel, Scott Joseph Antonia, Y. Bautista, Francesco Grossi, Dariusz Mirosław Kowalski, Gérard Zalcman, +11 more
11citations -
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 7432026 Journal of Clinical Oncology article Medicine Occupational and environmental lung diseases Open access
Arnaud Scherpereel, Paul Baas, Anna K. Nowak, Anne S. Tsao, Nobukazu Fujimoto, Solange Peters, +14 more
7citations -
LBA71 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (uMPM): 4-year update from CheckMate 7432022 Annals of Oncology conference-abstract Medicine Occupational and environmental lung diseases Open access
Gérard Zalcman, Y. Oulkhouir, Robin Cornelissen, Laurent Greillier, Jerónimo Rodríguez Cid, Julien Mazières, +12 more
7citations
Most active Aachen authors
-
Thomas Kraus 8,367 citations overall11 papers
-
Illaa Smesseim 193 citations overall7 papers
-
Julia Krabbe 346 citations overall6 papers
-
Danny David Jonigk 17,202 citations overall4 papers
-
Paul Baas 6,648 citations overall4 papers
-
Timm Dirrichs 1,296 citations overall2 papers
-
Dieter Veit 490 citations overall2 papers
-
Nelly Otte 39 citations overall2 papers
-
N Otte 0 citations overall2 papers
-
Willie J.G.M. Peijnenburg 30,179 citations overall1 paper
-
Maartje Nielsen 7,134 citations overall1 paper
-
André Esser 906 citations overall1 paper
-
Sarah Drießen 808 citations overall1 paper
-
Cornedine Jannette de Gooijer 565 citations overall1 paper
-
Michael K. Felten 488 citations overall1 paper